<code id='CE3FB554B8'></code><style id='CE3FB554B8'></style>
    • <acronym id='CE3FB554B8'></acronym>
      <center id='CE3FB554B8'><center id='CE3FB554B8'><tfoot id='CE3FB554B8'></tfoot></center><abbr id='CE3FB554B8'><dir id='CE3FB554B8'><tfoot id='CE3FB554B8'></tfoot><noframes id='CE3FB554B8'>

    • <optgroup id='CE3FB554B8'><strike id='CE3FB554B8'><sup id='CE3FB554B8'></sup></strike><code id='CE3FB554B8'></code></optgroup>
        1. <b id='CE3FB554B8'><label id='CE3FB554B8'><select id='CE3FB554B8'><dt id='CE3FB554B8'><span id='CE3FB554B8'></span></dt></select></label></b><u id='CE3FB554B8'></u>
          <i id='CE3FB554B8'><strike id='CE3FB554B8'><tt id='CE3FB554B8'><pre id='CE3FB554B8'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:explore    Page View:77747
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In